TCI Wealth Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-384
Closed -$3.77K 773
2023
Q1
$3.77K Sell
384
-331
-46% -$3.53K ﹤0.01% 1724
2022
Q4
$7.61K Hold
715
﹤0.01% 1255
2022
Q3
$7K Buy
715
+331
+86% +$4.31K ﹤0.01% 1237
2022
Q2
$5K Hold
384
﹤0.01% 1460
2022
Q1
$4K Buy
384
+77
+25% +$935 ﹤0.01% 1690
2021
Q4
$4K Hold
307
﹤0.01% 1796
2021
Q3
$6K Buy
+307
New +$4.08K ﹤0.01% 1443
2021
Q2
Sell
-202
Closed -$2K 2346
2021
Q1
$2K Buy
+202
New +$1.67K ﹤0.01% 1722

Other funds holding DVAX

TCI Wealth Advisors's DVAX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 384 shares — an estimated $3.77K sold.

TCI Wealth Advisors first reported a position in DVAX in Q1 2021 and held it in 8 quarters. The position peaked at $7.61K in Q4 2022. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 384 Dynavax Technologies shares in Q2 2023, an estimated $3.77K.
  • TCI Wealth Advisors first reported a position in Dynavax Technologies in Q1 2021 and held it in 8 quarters.
  • TCI Wealth Advisors's Dynavax Technologies position peaked at $7.61K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.